Juhani Knuuti
MD, professor, Turku PET Centre
jknuuti@utu.fi +358 29 450 2345 +358 50 059 2998 Kiinamyllynkatu 4-8 Turku |
Cardiovascular diseases, imaging
Juhani Knuuti’s research has focused on the physiology and pathophysiology, diagnosis and new therapies of coronary artery disease, heart failure and metabolic diseases. The research is also focused on developing and utilizing novel noninvasive imaging methods (PET, SPECT, echocardiography, MRI and CT) that will help to determine the risk and severity of CHD and heart failure and provide guidance for therapy decisions. The recent focus in cardiac research has been on vulnerable plaques, cardiac remodelling and multimodality and hybrid imaging. In metabolic and diabetes research, the focus has been in the interactions between different organs and heart in the pathogenesis and development of the cardiac diseases.
- Oxidative metabolism and cardiac work in different heart failure phenotypes (2022)
- EHJ Cardiovascular Imaging / European Heart Journal - Cardiovascular Imaging
- Performance of the American Heart Association/American College of Cardiology Guideline-Recommended Pretest Probability Model for the Diagnosis of Obstructive Coronary Artery Disease (2022)
- Journal of the American Heart Association
- PET imaging in diabetic cardiomyopathy (2022) Nuclear medicine and molecular imaging. Volume 3: Positron emission tomography studies Saraste Antti, Knuuti Juhani
- Prognostic implications of cardiac damage classification based on computed tomography in severe aortic stenosis (2022)
- EHJ Cardiovascular Imaging / European Heart Journal - Cardiovascular Imaging
- Prognostic Implications of Change in Left Ventricular Ejection Fraction After Transcatheter Aortic Valve Implantation (2022)
- American Journal of Cardiology
- Prognostic implications of staging cardiac remodeling in patients undergoing cardiac resynchronization therapy (2022)
- International Journal of Cardiology
- Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease (2022)
- Journal of Nuclear Cardiology
- Relationship between liver fat content and lifestyle factors in adults with metabolic syndrome (2022)
- Scientific Reports
- Sex differences in left ventricular remodelling in patients with severe aortic valve stenosis (2022)
- EHJ Cardiovascular Imaging / European Heart Journal - Cardiovascular Imaging
- Standing time and daily proportion of sedentary time are associated with pain-related disability in a one month accelerometer measurement in adults with overweight or obesity (2022)
- Scandinavian Journal of Pain
- Stress myocardial blood flow and revascularization in chronic coronary artery disease (2022)
- Journal of Nuclear Cardiology
- Subclinical leaflet thrombosis after transcatheter aortic valve implantation: no association with left ventricular reverse remodeling at 1-year follow-up (2022)
- International Journal of Cardiovascular Imaging
- Suomalaiset luottavat tieteeseen, mutta eivät kaikki (2022)
- Professoriblogi
- Targetting folate receptor-β expressing macrophages by 18F-labelled folate PET radiotracer in rat model of myocardial infarction (2022)
- European Journal of Nuclear Medicine and Molecular Imaging
- The Quantity of Epicardial Adipose Tissue in Patients Having Ablation for Atrial Fibrillation With and Without Heart Failure (2022)
- American Journal of Cardiology
- Tiedebarometri 2022: Suomi on edelleen luottamusyhteiskunta (2022)
- Turun Sanomat
- Time-resolved fluorescence based direct two-site apoA-I immunoassays and their clinical application in patients with suspected obstructive coronary artery disease (2022)
- Frontiers in Cardiovascular Medicine
- Tukea ukrainalaisille tieteentekijöille (2022)
- Professoriblogi
- Vessel and sex differences in pericoronary adipose tissue attenuation obtained with coronary CT in individuals without coronary atherosclerosis (2022)
- International Journal of Cardiovascular Imaging
- A specific plasma lipid signature associated with high triglycerides and low HDL cholesterol identifies residual CAD risk in patients with chronic coronary syndrome (2021)
- Atherosclerosis



